Serious infections with antirheumatic therapy: Are biologicals worse?

Research output: Contribution to journalArticle

35 Scopus citations

Abstract

This paper reviews the current evidence for the role of antirheumatic therapy in the development of serious infections in patients with rheumatoid arthritis (RA). Prednisone is clearly associated with increased infectious risk, but no definitive data link methotrexate to infection. Emerging data suggest that biological agents also pose increase infectious risk, particularly when used in combination with corticosteroids or methotrexate. Further research is needed in this important aspect of RA treatment. In the meantime, the author recommends that physicians should remain vigilant for serious infections in their patients with RA and use appropriate vaccines and screening procedures to mitigate their-risk.

Original languageEnglish (US)
Pages (from-to)iii54-iii57
JournalAnnals of the rheumatic diseases
Volume65
Issue numberSUPPL. 3
DOIs
StatePublished - Nov 2006

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Serious infections with antirheumatic therapy: Are biologicals worse?'. Together they form a unique fingerprint.

Cite this